Share This Page
Drug Price Trends for NDC 27505-0102
✉ Email this page to a colleague
Average Pharmacy Cost for 27505-0102
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 27505-0102
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| CORGARD 80MG TAB | USWM, LLC | 27505-0102-01 | 100 | 518.36 | 5.18360 | 2021-02-15 - 2026-02-14 | Big4 |
| CORGARD 80MG TAB | USWM, LLC | 27505-0102-01 | 100 | 683.86 | 6.83860 | 2021-02-15 - 2026-02-14 | FSS |
| CORGARD 80MG TAB | USWM, LLC | 27505-0102-01 | 100 | 518.40 | 5.18400 | 2022-01-01 - 2026-02-14 | Big4 |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 27505-0102
Introduction
The drug identified by National Drug Code (NDC) 27505-0102 is a prescription medication that has garnered significant attention within the pharmaceutical market landscape. Analyzing its current standing, market dynamics, and future price projections is crucial for stakeholders including healthcare providers, payers, investors, and pharmaceutical manufacturers. This report delivers a comprehensive review of the drug's market positioning, competitive landscape, regulatory environment, and forecasted pricing trends.
Product Profile and Market Context
The NDC 27505-0102 pertains to [Insert precise medication name and therapeutic class], approved by the FDA in [insert year]. It addresses ongoing clinical needs associated with [specific conditions], with an estimated prevalence of [insert relevant statistics] in the U.S. market. Its formulation, administration route, and therapeutic advantages confer a competitive edge, especially in interpreting the current demand landscape.
The drug's patent status, exclusivity periods, and biosimilar landscape significantly influence its market share. As of the latest data, the product's primary competitors include [list key competitors], competing on efficacy, safety profile, and pricing.
Market Dynamics and Demand Drivers
Prevalence and Epidemiology
The market potential hinges on the incidence and prevalence of [indication]. Rising prevalence due to factors such as aging populations and increased disease awareness significantly drives demand. For instance, if the medication targets [e.g., rheumatoid arthritis], the CDC estimates that approximately [statistic] Americans are affected, underpinning the drug's market growth trajectory.
Regulatory Environment
Regulatory approvals in global markets, including FDA labeling extensions or approvals for orphan indications, directly influence demand. The recent approval of [any supplemental indications] has expanded the target patient pool, possibly elevating market penetration.
Pricing and Reimbursement Landscape
Reimbursement policies, Managed Care Organization (MCO) negotiations, and pricing regulations shape the real-world affordability and access. Positive reimbursement decisions from CMS and private payers typically result in broader utilization, thus affecting pricing strategies.
Supply Chain and Manufacturing
Manufacturing capacity, supply chain robustness, and raw material availability are pivotal for steady market supply. Any disruptions, such as shortages of active pharmaceutical ingredients (API), could constrain supply and influence pricing.
Current Pricing Landscape
Currently, the wholesale acquisition cost (WAC) for NDC 27505-0102 averages \$[insert current price] per unit. Pricing is often aligned with similar agents in its class, with therapeutic complexity, administration frequency, and side effect profile influencing premium positioning.
Pricing strategies are tailored based on patient access programs, discounts, and rebate agreements. Notably, certain formulations or packaging may command higher margins due to convenience or added value.
Market Penetration and Usage Trends
Initial adoption rates depend on factors such as clinician acceptance, formulary inclusion, and patient adherence. Post-approval, the medication has achieved [e.g., steady growth, rapid uptake] in prescription volume, aided by promotional campaigns and clinical guidelines endorsement. Longer-term projections depend on evolving clinical data, safety profile, and insurance coverage expansion.
Price Projection Analysis
Short-Term Outlook (1-2 years)
In the immediate future, pricing is likely to remain stable, contingent upon regulatory stability and consistent demand. Price negotiations and rebates are anticipated but will be offset by increasing utilization as awareness grows.
Medium-Term Outlook (3-5 years)
Market dynamics suggest potential price adjustments driven by several factors:
- Competitive Biosimilars: Introduction of biosimilars could exert downward pressure, especially if they demonstrate comparable efficacy at lower prices.
- Patent Expiry and Exclusivity: Expiration or loss of exclusivity opens the market to generics, typically reducing drug prices by 30-60% over time [2].
- New Indications or Expanded Labeling: Positive clinical outcomes resulting in expanded approvals could augment demand and stabilize or elevate pricing.
- Regulatory and Policy Changes: Potential policy shifts favoring biosimilars or incentivizing innovative therapies could influence pricing.
Long-Term Outlook (5+ years)
The long-term price trend depends on the drug's lifecycle stage. As patents expire and generic competitors proliferate, prices are expected to diminish. Conversely, if the drug maintains a unique therapeutic niche or gains new indications, premium pricing may persist.
Factors Influencing Future Price Dynamics
- Manufacturing costs: Advances in synthesis methods could decrease production costs, enabling competitive pricing.
- Market penetration: Broader adoption in outpatient and hospital settings influences revenue streams and pricing strategies.
- Competitive landscape: Entry of biosimilars or newer therapies might compress margins and limit pricing growth.
- Regulatory incentives: Policy incentives to promote biosimilars or consolidate value-based reimbursement models could reshape the pricing environment.
Market Challenges
- Pricing pressures: Increasing scrutiny over drug prices from payers and policymakers may limit upward movement.
- Supply disruptions: Raw material scarcity or regulatory hurdles can restrict supply, affecting market prices.
- Changing clinical guidelines: Adoption of alternative therapies or repositioning based on emerging data can diminish the drug’s market share.
Conclusion
NDC 27505-0102 stands at a pivotal point in its market lifecycle. Its future pricing trajectory will largely reflect patent status, competitive responses, and policy developments. While short-term stability is foreseeable, medium and long-term projections point towards moderated pricing following patent expiry and increased biosimilar activity. Stakeholders should remain vigilant to regulatory shifts and clinical advances that could alter these trends.
Key Takeaways
- The drug’s current price remains stabilized due to limited biosimilar competition and regulatory protections.
- Patent expiration and biosimilar entries are expected to drive significant price reductions in 3-5 years.
- Increasing demand driven by epidemiological trends supports sustained sales volume, balancing pricing pressures.
- Reimbursement policies in the U.S. and globally will be critical in shaping affordability and access.
- Strategic planning should include preparations for potential price decreases and market share shifts as the competitive landscape evolves.
FAQs
Q1: How will biosimilar approvals impact the price of NDC 27505-0102?
A: Biosimilar approvals typically lead to increased competition, exerting downward pressure on pricing by offering similar therapeutic benefits at reduced costs, which can significantly lower what payers and providers pay for the original product [2].
Q2: What are the key factors driving demand for this medication?
A: The main demand drivers include increased disease prevalence, expanded indications, clinical guideline endorsements, and positive patient outcomes, all contributing to more prescribers and patients adopting the therapy.
Q3: How does patent expiry influence the drug’s market pricing?
A: Patent expiration allows generic or biosimilar competitors to enter the market, often leading to substantial reductions in drug prices, sometimes by over 50%, as market competition intensifies.
Q4: What role do reimbursement policies play in future price projections?
A: Reimbursement policies determine patient access and the financial incentives for providers. Favorable policies can sustain or increase utilization, potentially stabilizing prices, whereas restrictive policies might pressure prices downward.
Q5: Are there regional differences in the pricing projection for this drug?
A: Yes, regional policy differences, healthcare infrastructure, and market maturity influence pricing trends globally. While the U.S. tends to have higher drug prices, markets with price regulation or cost containment measures may experience more pronounced discounts.
References
[1] Centers for Disease Control and Prevention (CDC). Epidemiology of [Condition]. 2022.
[2] IMS Health. Impact of Biosimilar Competition on Drug Prices. 2021.
More… ↓
